Amgen, Inc. (AMGN) Dividend Details and dates on NASDAQ

Amgen, Inc. Dividend Stock Review


Amgen, Inc. (AMGN) Dividend Details and dates on NASDAQ

Amgen, Inc. Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Sector: Health Technology Biotechnology

Dividend income advisory for AMGN
Dividend Yield for AMGN
The expected yield for AMGN is 3.15 %, this seems a healthy dividend return and if Amgen, Inc. is also cheaply priced, and has a low debt to equity ratio and if Amgen, Inc. makes a good profit.

How is AMGN priced
AMGN has a trailing price to earnings ratio (P/E) of 13.62. The ratio is determined by the performance in the last 12 months. The P/E ratio is smaller than 20, which we consider a healthly ratio.

Debt to equity of AMGN
With the Debt To Equity rate of AMGN (2.71) we can conclude that Amgen, Inc. has more external liabilities than equity provided by shareholders. The company is leveraging it's investments with external cash. This can result in more returns but comes at a higher risk.

Price Prediction for AMGN
On average analists predict that AMGN will be correctly priced after a 21%. change. We can expect some long term capital gains.

Upcoming Dividends for AMGN
No Upcoming dividends declared.

Dividends in past 12 months AMGN
Declared Ex Dividend Date Payment Date Record Date Amount Frequency
2019-08-02 2019-08-14 2019-09-06 2019-08-15 1.45 USD Quarterly
2019-03-07 2019-05-16 2019-06-07 2019-05-17 1.45 USD Quarterly
2018-12-07 2019-02-14 2019-03-08 2019-02-15 1.45 USD Quarterly
2018-10-23 2018-11-15 2018-12-07 2018-11-16 1.32 USD Quarterly
2018-07-31 2018-08-16 2018-09-07 2018-08-17 1.32 USD Quarterly

Historical Dividends & Cap Growth for AMGN
Past 5 Year Capital Gains 22.44 %
Dividend yield 13.55 %
Growth including dividends 35.99%
Latest news for AMGN

2019-08-14 Amgen (AMGN) Soars to 52-Week High, Time to Cash Out? Amgen (AMGN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Original Article @ Zacks Investment Research

2019-08-14 Biotech Stock Roundup: Amgen's Enbrel Patent Win, AMRN's Setback & More Key highlights of the past week include collaborations, and other regulatory and pipeline news.
Original Article @ Zacks Investment Research

2019-08-14 Zacks Industry Outlook Highlights: Gilead Sciences, Regeneron Pharmaceuticals, Amgen, Vertex Pharmaceuticals and Alexion Pharmaceuticals Zacks Industry Outlook Highlights: Gilead Sciences, Regeneron Pharmaceuticals, Amgen, Vertex Pharmaceuticals and Alexion Pharmaceuticals
Original Article @ Zacks Investment Research

2019-08-13 Should Value Investors Choose Amgen (AMGN) Stock Now? Let's see if Amgen (AMGN) stock is a good choice for value-oriented investors right now from multiple angles.
Original Article @ Zacks Investment Research

2019-08-13 Will Amgen Continue to Surge Higher? As of late, it has definitely been a great time to be an investor Amgen.
Original Article @ Zacks Investment Research

2019-08-12 Stocks slide as unrest in Hong Kong shakes already-rattled investors Stocks slipped on Monday as thousands of demonstrators forced Hong Kong's main airport to cancel all flights in the latest escalation of protests within city. The shutdown piles onto investors existing concerns over the global economy amid a deteriorating outlook for a trade deal between the US and China. Shares of Cathay Pacific, Hong Kong's dominant airline, plummeted as much as 4.9% to decade lows after China demanded that it prevent protesting employees from flying to the mainland. The US budget deficit in 2019 has grown larger than the entire deficit for last year, according to the Treasury Department's monthly report. Visit the Markets Insider homepage for more stories . Stocks fell on Monday as flaring political unrest in Hong Kong rocked markets already fragile from a deteriorating outlook for a US-China trade deal. Hong Kong's airport was forced to cancel more than 100 flights on Monday after thousands of demonstrators clogged departure and arrival halls preventing passengers from boarding any planes.
Original Article @ Business Insider

2019-08-12 Amgen stock gets boost from Friday ruling on Enbrel Shares of Amgen Inc. rose another 4.5% on Monday after gaining nearly 6% on Friday, when a U.S. judge upheld two patents related to the pharmaceutical…
Original Article @ MarketWatch

2019-08-12 Stocks making the biggest moves midday: Roku, Capri Holdings, Amgen, Deere & more Check out the companies making headlines midday on Monday.
Original Article @ CNBC

2019-08-12 Amgen Wins Enbrel U.S. Patent Litigation Against Novartis Despite lower demand hurting volumes of Enbrel, it remains the largest drug for Amgen (AMGN). A district court decision prevents Novartis from launching Erelzi, its biosimilar version of Enbrel.
Original Article @ Zacks Investment Research

2019-08-09 Stocks slump as US-China trade tensions escalate yet again Stocks fell on Friday as trade tensions resumed between China and the US after President Trump suggested he could cancel upcoming negotiations in September. While speaking to the press at the White House, Trump told reporters that he wasn't ready to make a deal with China. The president also said the US would officially sever ties with Huawei, a Chinese telecommunications company at the center of the trade war. Visit the Markets Insider homepage for more stories . Stocks returned to a downward spiral on Friday after President Trump floated the idea of canceling upcoming trade talks with China in September, bringing into question whether the world's two largest economies can avoid escalating their trade war. While speaking to reporters on the South Lawn of the White House, Trump was asked whether the planned talks with China would be cancelled, to which Trump replied: "Maybe. We'll see what happens." The comments come a few weeks before a new round of tariffs on $300 billion worth of Chinese exports are scheduled to take effect on September 1.
Original Article @ Business Insider

Dividend Stats For AMGN

  • Current Dividend Yield 3.15%
  • Past Year Payout: 6.99 USD
  • Next Ex Dividend Undeclared
  • Next Payment: N/A USD
  • Our score 87 %

Related dividend stocks